Background Alzheimer's disease (AD) is a complicated neurodegenerative disease with
cognitive impairment occurring in the older people, in which extracellular accumulation of β …

In recent decades, the impairment of cholesterol metabolism in the pathogenesis of
Alzheimer's disease (AD) has been intensively investigated, and it has been recognized to …

Lipid-mediated signalling regulates a plethora of physiological processes, including crucial
aspects of brain function. In addition, dysregulation of lipid pathways has been implicated in …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that currently affects
millions of Americans. There is no cure at present and no real long-term hope for patients …

Alzheimer's disease (AD) is the most common form of dementia and it is characterized by the
deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. However, the …

Alzheimer's disease, one of the most rapidly growing neurodegenerative disorders, is
characterized by a progressive loss of memory. Despite several advances in the field of …

Several recent reports provided important knowledge on how “inhibiting cholesterol
production in the brain might inhibit amyloid b (Ab) ABBR production, and reduce the …

Alzheimer's disease (AD) is an age-related, progressive neurodegenerative disorder
characterized by impaired cognition, memory loss, and altered personality. Many of the …

Background—Alzheimer's disease (AD) is a multifactorial, progressive, neurodegenerative
disease that is characterized by memory loss, personality changes, and a decline in …

Abstract Alzheimer's disease (AD), a type of dementia, severely distresses different brain
regions. Characterized by various neuropathologies, it interferes with cognitive functions …